Chemoinformaics analysis of Ethyl 3-acetoxyoctanoate
| Molecular Weight | 230.304 | nRot | 8 |
| Heavy Atom Molecular Weight | 208.128 | nRig | 2 |
| Exact Molecular Weight | 230.152 | nRing | 0 |
| Solubility: LogS | -2.388 | nHRing | 0 |
| Solubility: LogP | 2.95 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 37.9174 |
| nHD | 0 | BPOL | 27.2786 |
| QED | 0.475 |
| Synth | 2.53 |
| Natural Product Likeliness | 1.354 |
| NR-PPAR-gamma | 0.695 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.467 |
| MDCK | 0.0000478 |
| BBB | 0.965 |
| PPB | 0.780757 |
| VDSS | 0.657 |
| FU | 0.258916 |
| CYP1A2-inh | 0.505 |
| CYP1A2-sub | 0.094 |
| CYP2c19-inh | 0.138 |
| CYP2c19-sub | 0.361 |
| CYP2c9-inh | 0.129 |
| CYP2c9-sub | 0.186 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.123 |
| CYP3a4-inh | 0.186 |
| CYP3a4-sub | 0.28 |
| CL | 6.357 |
| T12 | 0.789 |
| hERG | 0.01 |
| Ames | 0.026 |
| ROA | 0.01 |
| SkinSen | 0.922 |
| Carcinogencity | 0.42 |
| EI | 0.96 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.680162 |